Dr. Srikant Nannapaneni
Claim this profileCox South Hospital
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Srikant Nannapaneni is currently running
Surgical Excision Margins
for Melanoma
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting2 awards Phase 39 criteria
Nanosomal Docetaxel
for Triple Negative Breast Cancer
This trial tests a new, safer form of the cancer drug docetaxel, called Nanosomal Docetaxel Lipid Suspension (NDLS), in patients with advanced or spreading triple-negative breast cancer. NDLS aims to reduce side effects by using tiny fat particles. The drug works by stopping cancer cells from dividing and growing. Docetaxel is a widely used chemotherapy drug, and newer formulations like Nanosomal Docetaxel Lipid Suspension (NDLS) aim to improve its efficacy and reduce toxicity.
Recruiting4 awards Phase 313 criteria
More about Srikant Nannapaneni
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Srikant Nannapaneni has experience with
- Wide Local Excision = 1cm Margin
- Wide Local Excision = 2cm Margin
- Nanosomal Docetaxel Lipid Suspension
Breakdown of trials Srikant Nannapaneni has run
Skin Cancer
Cutaneous Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Srikant Nannapaneni specialize in?
Srikant Nannapaneni focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage II patients, or patients who are undergoing treatment.
Is Srikant Nannapaneni currently recruiting for clinical trials?
Yes, Srikant Nannapaneni is currently recruiting for 2 clinical trials in Springfield Missouri. If you're interested in participating, you should apply.
Are there any treatments that Srikant Nannapaneni has studied deeply?
Yes, Srikant Nannapaneni has studied treatments such as Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin, Nanosomal Docetaxel Lipid Suspension.
What is the best way to schedule an appointment with Srikant Nannapaneni?
Apply for one of the trials that Srikant Nannapaneni is conducting.
What is the office address of Srikant Nannapaneni?
The office of Srikant Nannapaneni is located at: Cox South Hospital, Springfield, Missouri 65807 United States. This is the address for their practice at the Cox South Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.